ALGT vs SEPN
ALGT: Allegiant Travel Company is a low-cost, leisure-focused airline that connects travelers from smaller cities to vacation destinations while bundling complementary travel services. SEPN: Septerna is a biotechnology company pioneering a new approach to unlock the therapeutic potential of G protein-coupled receptors (GPCRs) through oral small molecule drug discovery.
Side-by-side fundamentals
| Metric | ALGT | SEPN | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $71.34 | $44.00 | |
| Market cap | $2.0B | $2.1B | |
| P/E as of 2026-10-30 | 61.50 | n/a | |
| Net margin FY2025, SEC XBRL | -1.7% | -106.4% | ALGT higher |
| Operating margin FY2025, SEC XBRL | +1.4% | -148.6% | ALGT higher |
| ROE FY2025, SEC XBRL | -4.2% | -12.8% | ALGT higher |
| ROA FY2025, SEC XBRL | -1.1% | -8.2% | ALGT higher |
| Debt / equity | 1.56 | 0.00 | SEPN lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +3.7% | +4174.5% | SEPN higher |
| Revenue CAGR (3y) SEC XBRL | +4.2% | +1644.5% | SEPN higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 1.94 | 1.25 | |
| 1-year return as of 2026-10-30 close | +16.8% | +104.7% | SEPN higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.